Kiniksa Pharmaceuticals International (KNSA) Technical Analysis

As of 2026-07-22, KNSA last traded at 62.44 USD (-1.75% on the day) and is in a uptrend on the daily timeframe — price above rising 50-DMA, 50-DMA above 200-DMA. Nearest levels: 46.1 USD support below, 67.53 USD resistance above. 14-day RSI is 49.1 (neutral).

Last updated 2026-07-22 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

Is KNSA in an uptrend or downtrend?

Kiniksa Pharmaceuticals International is in a uptrend — price above rising 50-DMA, 50-DMA above 200-DMA.

Last close62.44 USD (-1.75%)
20-day average62.544 USD
50-day average56.738 USD
200-day average46.795 USD

Key support and resistance levels for KNSA

Derived from swing pivots over the last 200 sessions:

LevelTypeStrengthTouches
67.53 USDResistanceMinor1
LevelTypeStrengthTouches
46.1 USDSupportMinor1
44.38 USDSupportModerate2
41.98 USDSupportMinor1

KNSA 52-week range, momentum and volatility

52-week high67.53 USD (7.5% below)
52-week low26.27 USD (137.7% above)
14-day RSI49.1 (Neutral)
14-day ATR2.789 USD (4.47% of price, High volatility)

Related research pages

Frequently asked questions

Is Kiniksa Pharmaceuticals International (KNSA) in an uptrend or downtrend?

As of 2026-07-22, KNSA is in a uptrend on the daily timeframe — price above rising 50-DMA, 50-DMA above 200-DMA. Last close 62.44 USD vs 50-day average 56.738 USD and 200-day average 46.795 USD.

What are the key support and resistance levels for KNSA?

Nearest support is around 46.1 USD (minor, 1 touch). Nearest resistance is around 67.53 USD (minor). Levels are derived from swing pivots over the last ~200 sessions.

What is KNSA's 52-week high and low?

Over the last 52 weeks, KNSA traded between 26.27 USD and 67.53 USD. It is currently 7.5% below its 52-week high.

Is KNSA overbought or oversold?

The 14-day RSI is 49.1 — in a neutral 30–70 range. Momentum reads as neutral.

How volatile is KNSA?

Its 14-day Average True Range is 2.789 (4.47% of price) — high volatility relative to price.